De novo variants in GATAD2A in individuals with a neurodevelopmental disorder: GATAD2A-related neurodevelopmental disorder.
De novo variants in GATAD2A in individuals with a neurodevelopmental disorder: GATAD2A-related neurodevelopmental disorder.
复制标题
DOI:
10.1016/j.xhgg.2023.100198
复制
发表时间:
2023-07-13
期刊:
影响因子:
--
通讯作者:
Martin, Donna M.
中科院分区:
文献类型:
--
作者:
Werren, Elizabeth A.;Guxholli, Alba;Jones, Natasha;Wagner, Matias;Hannibal, Iris;Granadillo, Jorge L.;Tyndall, Amanda, V;Moccia, Amanda;Kuehl, Ryan;Levandoski, Kristin M.;Day-Salvatore, Debra L.;Wheeler, Marsha;Chong, Jessica X.;Bamshad, Michael J.;Innes, A. Micheil;Pierson, Tyler Mark;Mackay, Joel P.;Bielas, Stephanie L.;Martin, Donna M.
GATA zinc finger domain containing 2A (GATAD2A) is a subunit of the nucleosome remodeling and deacetylase (NuRD) complex. NuRD is known to regulate gene expression during neural development and other processes. The NuRD complex modulates chromatin status through histone deacetylation and ATP-dependent chromatin remodeling activities. Several neurodevelopmental disorders (NDDs) have been previously linked to variants in other components of NuRD’s chromatin remodeling subcomplex (NuRDopathies). We identified five individuals with features of an NDD that possessed de novo autosomal dominant variants in GATAD2A. Core features in affected individuals include global developmental delay, structural brain defects, and craniofacial dysmorphology. These GATAD2A variants are predicted to affect protein dosage and/or interactions with other NuRD chromatin remodeling subunits. We provide evidence that a GATAD2A missense variant disrupts interactions of GATAD2A with CHD3, CHD4, and CHD5. Our findings expand the list of NuRDopathies and provide evidence that GATAD2A variants are the genetic basis of a previously uncharacterized developmental disorder. Genetic variants in several members of the nucleosome remodeling and deacetylase (NuRD) complex are associated with distinct neurodevelopmental disorders. Our findings implicate the NuRD member, GATAD2A, in a neurodevelopmental disorder and demonstrate the need to identify additional genetic variants to define the clinical spectrum of NuRD-related disorders.
登录
查看更多内容
影响因子:
9.3
作者:
Li J;Ma Z;Shi M;Malty RH;Aoki H;Minic Z;Phanse S;Jin K;Wall DP;Zhang Z;Urban AE;Hallmayer J;Babu M;Snyder M
通讯作者:
Snyder M
影响因子:
8.8
作者:
Nitarska J;Smith JG;Sherlock WT;Hillege MM;Nott A;Barshop WD;Vashisht AA;Wohlschlegel JA;Mitter R;Riccio A
通讯作者:
Riccio A
影响因子:
4.8
作者:
Brackertz, M;Boeke, J;Renkawitz, R
通讯作者:
Renkawitz, R
影响因子:
3.7
作者:
Marino S;Nusse R
通讯作者:
Nusse R
影响因子:
8.8
作者:
Spruijt, Cornelia G.;Luijsterburg, Martijn S.;Vermeulen, Michiel
通讯作者:
Vermeulen, Michiel